Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Is it cancer? A combination non-invasive approach to determine if indeterminate pulmonary nodules are cancerous
From Dr. Paul Lampe, Translational Research Program and Cancer Epidemiology, Prevention and Control of the Cancer Consortium, and Dr. Paul Kinahan, University of Washington.
CAF-like cells remodel the Ewing sarcoma tumor microenvironment
From the Lawlor lab, Seattle Children’s Hospital and the Cancer Basic Biology Program of the Cancer Consortium
A promising program for cancer intervention in rural communities
From the Health Communication Research Center, Public Health Sciences Division and the Cancer Epidemiology, Prevention and Control Program of the Cancer Consortium
Una clave de la metástasis del cáncer de mama se esconde en las diminutas cavidades entre las células
Del Laboratorio Cheung, Programa de cánceres de mama y ovario, Consorcio del cáncer.
Boost and attack approach for metastatic prostate cancer therapy!
From the Lee Lab, Human Biology and Clinical Research Divisions, Cancer Consortium
Dr. Sara Hurvitz joins Fred Hutch, University of Washington
Longtime UCLA breast oncologist and international expert will be senior vice president of the Clinical Research Division
Hitting ‘undo’ to cure Sickle Cell Disease
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
A user-friendly toolkit for cancer control planning
From the Ramsey Group, Cancer Epidemiology, Prevention, and Control Research Program, Cancer Consortium
When more is better: bevacizumab treatment for patients with ovarian cancer
From the Liao Group, Breast and Ovary Cancers Research Program, Cancer Consortium
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
The future of blood stem cell gene therapy is in vivo
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Enhance, enhance! Computational tool “BayesSpace” zooms in to fine-map spatial transcriptomics
From the Gottardo, Bielas, and Nghiem Labs, Biostatistics and Computational Biology Program, Cancer Consortium
A key to breast cancer metastasis lurks in the tiny cavities between cells
From the Cheung Lab, Breast and Ovary Cancers Program, Cancer Consortium
How the Gale Lab “RIG”s innate immune responses against hepatitis B
From the Gale Lab, Pathogen Associated Malignancies Program, Cancer Consortium
Red Light, Green Light: Precise cell targeting with Co-LOCKR
From the Baker, Riddell, and Pun Labs, Cancer Basic Biology, Cancer Consortium
Fred Hutch/University of Washington Cancer Consortium to serve entire state
Catchment area expands from 13 counties to all of Washington, adding 2.4 million people and several additional Indigenous tribes
Nanoparticles with a mega impact: how injectable mRNA fights cancer
From the Stephan Lab and Nelson Lab, Cancer Immunology Program, Cancer Consortium
In research and cancer care, Indigenous representation matters
Fred Hutch, UW researchers work to reduce risk and inequities and improve access to care, resources for Indigenous communities and patients
Dr. Christopher Li named associate director of Diversity, Equity and Inclusion for Fred Hutch/UW Cancer Consortium
New role will enable the Consortium to serve as national leader in DEI
Bringing science and better health outcomes to all
Fred Hutch’s Pathways to Equity Symposium: Heartbreaking statistics, hopeful plans, and recognition for a pair of health-equity trailblazers